- Home
- CION vs ORGO Comparison
CION vs ORGO Comparison
Compare CION & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CION
- ORGO
- Stock Information
- Founded
- CION 2011
- ORGO 1985
- Country
- CION United States
- ORGO United States
- Employees
- CION N/A
- ORGO N/A
- Industry
- CION Finance/Investors Services
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- CION Finance
- ORGO Health Care
- Exchange
- CION Nasdaq
- ORGO Nasdaq
- Market Cap
- CION 533.9M
- ORGO 620.3M
- IPO Year
- CION N/A
- ORGO N/A
- Fundamental
- Price
- CION $9.51
- ORGO $4.28
- Analyst Decision
- CION Sell
- ORGO Buy
- Analyst Count
- CION 1
- ORGO 3
- Target Price
- CION $8.50
- ORGO $7.33
- AVG Volume (30 Days)
- CION 274.1K
- ORGO 585.8K
- Earning Date
- CION 11-06-2025
- ORGO 11-06-2025
- Dividend Yield
- CION 15.80%
- ORGO N/A
- EPS Growth
- CION N/A
- ORGO N/A
- EPS
- CION N/A
- ORGO N/A
- Revenue
- CION $225,839,000.00
- ORGO $429,531,000.00
- Revenue This Year
- CION N/A
- ORGO $2.51
- Revenue Next Year
- CION N/A
- ORGO $25.45
- P/E Ratio
- CION N/A
- ORGO N/A
- Revenue Growth
- CION N/A
- ORGO N/A
- 52 Week Low
- CION $8.51
- ORGO $2.61
- 52 Week High
- CION $12.71
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- CION 49.68
- ORGO 51.91
- Support Level
- CION $9.41
- ORGO $4.04
- Resistance Level
- CION $9.52
- ORGO $4.39
- Average True Range (ATR)
- CION 0.19
- ORGO 0.15
- MACD
- CION 0.05
- ORGO 0.04
- Stochastic Oscillator
- CION 91.11
- ORGO 80.00
About CION CION Investment Corporation
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.